Physicians also expect greater use of Johnson & Johnson’s Varipulse system over the next two years despite the company’s ...
One year into the U.S. launch of pulsed field ablation systems from Boston Scientific and Medtronic, doctors in a survey said they planned to use the technology in about 56% of ablation procedures ...
Medtronic's next-gen renal denervation catheter and procedure are in the works to advance the FDA-approved Symplicity Spyral ...
Medtronic is a solid dividend-paying stock. Its stock recently yielded 3.2%. It has increased its payout for nearly 50 years in a row. If you're a dividend investor, I can understand why ...
Stereotaxis said today that it has secured CE mark approval for its Magic robotically-navigated magnetic ablation catheter.
Pulsed field ablation (PFA) is a treatment for atrial fibrillation ... PFA revenue exploded in Q1 2024 after FDA approvals for Boston Scientific’s FARAPULSE and Medtronic’s PulseSelect. Over the last ...
GlobalData on MSN2d
Stereotaxis wins European approval for robotic ablation catheterStereotaxis has won European CE mark approval for its MaGiC ablation catheter, a robotically navigated device for the ...
George H. Crossley, M.D.; Kazutaka Aonuma, M.D.; Charles Haffajee, M.D.; Morio Shoda, M.D.; Albert Meijer, M.D.; Alexander Bauer, M.D.; Alexander Bauer, M.D ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback